Brief: Oncopeptides Q2 Operating Profit SEK -62.43 Million
10/08/2023 07:00
Aug 10 (Reuters) - Oncopeptides Q2 adjusted EPS SEK -0.62. * Q2 net income SEK -56.332 million * Q2 adjusted free cash flow SEK -77.308 million * Q2 sales SEK 25.954 million
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy